Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by METTLER TOLEDO. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by METTLER TOLEDO or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Prescription to Pop Culture: How GLP-1s Are Shaking up the Weight Loss and Health Care Industries

33:21
 
Share
 

Manage episode 487847047 series 3598799
Content provided by METTLER TOLEDO. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by METTLER TOLEDO or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

If you haven’t heard of GLP-1s, you’ve almost certainly come across the brand names: Ozempic, Wegovy, and Mounjaro. These drugs were originally developed to treat diabetes, but they’ve recently become household names thanks to their dramatic impact on weight loss. Beyond shedding pounds, early evidence also points to promising benefits for chronic kidney disease, certain liver conditions, and cardiovascular health.

But with surging demand for GLP-1s driven by their weight-loss potential, there’s growing concern about access for those who rely on them for critical medical conditions. As supply chains stretch thin, the ripple effects are being felt in unexpected places, including the rise of gray and black markets offering questionable or counterfeit alternatives to meet unmet demand.

In this episode of Balancing the Future, Micah and Chai are joined by Ben Locwin, Chief Scientist and Head of Clinical Services at Black Diamond Networks. Together, they unpack the meteoric rise of GLP-1s in popular culture and how platforms like TikTok and Instagram have helped fuel the frenzy. They also examine the darker undercurrents of that attention: underground sales, off-label usage, and inequities in access.

One emerging issue is sustainability. Most GLP-1s are delivered via disposable, single-use pens or prefilled syringes, products that are difficult to recycle and often end up in landfills or as medical waste. As millions more people begin using these injectables, the environmental cost is becoming impossible to ignore. The reliance on needles also poses challenges for people who have a fear of injections or are unwilling to self-administer shots regularly, increasing pressure on pharmaceutical companies to fast-track the development of oral alternatives.

Ben Locwin brings deep insight as a healthcare executive, medical scientist, TEDx speaker, and frequent contributor to outlets like The Wall Street Journal, Forbes, and NPR.

LINKS

SOURCES

The GLP-1 journey: from discovery science to therapeutic impact – PubMed Central

The Ozempic Effect: Everything You Need to Know About Medical Weight Loss - Columbia University Department of Surgery

Adderall - Encyclopædia Britannica

Early development history of Botox (onabotulinumtoxinA) - PubMed Central

A Snapshot History of Botox - Dimensionz Injectables

How to prevent gray market activities: A comprehensive checklist for pharmaceutical companies - Systech

FDA Approves First Over-the-Counter Naloxone Nasal SprayUS. Food and Drug Administration

Oral Insulin: The Rationale for This Approach and Current Developments - PubMed Central

ABOUT BALANCING THE FUTURE

Join Micah Schweizer and new host Chai Nussbaumer on Balancing the Future as they dive into the innovations shaping our world. From the potential of hydrogen in powering a greener planet, to the rise of GLP-1s in weight loss, and the frontier of microbiome-based treatments, they explore the science that's transforming our lives.

Each episode features in-depth conversations with scientists, communicators, and thought leaders pushing the boundaries of what’s possible. They also explore the impact these breakthroughs will have on a world in desperate need of sustainable solutions today.


ABOUT METTLER TOLEDO LAB SOLUTIONS:

In the fast-paced world of laboratory science, precision and efficiency are everything. That’s why METTLER TOLEDO is committed to delivering cutting-edge laboratory solutions that streamline workflows and enhance productivity. Our comprehensive portfolio includes high-performance instruments, intuitive software, automation technologies, consumables, accessories, and expert services—each engineered to meet the unique needs of industries such as pharmaceuticals, food and beverage, chemicals, biotechnology, and both QA/QC and R&D laboratories.

From precision and analytical balances to advanced titrators, pH meters, density meters, refractometers, melting point instruments, and more, METTLER TOLEDO products are designed for accuracy, reliability, and ease of use. Our solutions empower laboratories to generate trusted results, maintain compliance, and ensure maximum uptime with our robust lifecycle services and automation capabilities.

  continue reading

14 episodes

Artwork
iconShare
 
Manage episode 487847047 series 3598799
Content provided by METTLER TOLEDO. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by METTLER TOLEDO or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

If you haven’t heard of GLP-1s, you’ve almost certainly come across the brand names: Ozempic, Wegovy, and Mounjaro. These drugs were originally developed to treat diabetes, but they’ve recently become household names thanks to their dramatic impact on weight loss. Beyond shedding pounds, early evidence also points to promising benefits for chronic kidney disease, certain liver conditions, and cardiovascular health.

But with surging demand for GLP-1s driven by their weight-loss potential, there’s growing concern about access for those who rely on them for critical medical conditions. As supply chains stretch thin, the ripple effects are being felt in unexpected places, including the rise of gray and black markets offering questionable or counterfeit alternatives to meet unmet demand.

In this episode of Balancing the Future, Micah and Chai are joined by Ben Locwin, Chief Scientist and Head of Clinical Services at Black Diamond Networks. Together, they unpack the meteoric rise of GLP-1s in popular culture and how platforms like TikTok and Instagram have helped fuel the frenzy. They also examine the darker undercurrents of that attention: underground sales, off-label usage, and inequities in access.

One emerging issue is sustainability. Most GLP-1s are delivered via disposable, single-use pens or prefilled syringes, products that are difficult to recycle and often end up in landfills or as medical waste. As millions more people begin using these injectables, the environmental cost is becoming impossible to ignore. The reliance on needles also poses challenges for people who have a fear of injections or are unwilling to self-administer shots regularly, increasing pressure on pharmaceutical companies to fast-track the development of oral alternatives.

Ben Locwin brings deep insight as a healthcare executive, medical scientist, TEDx speaker, and frequent contributor to outlets like The Wall Street Journal, Forbes, and NPR.

LINKS

SOURCES

The GLP-1 journey: from discovery science to therapeutic impact – PubMed Central

The Ozempic Effect: Everything You Need to Know About Medical Weight Loss - Columbia University Department of Surgery

Adderall - Encyclopædia Britannica

Early development history of Botox (onabotulinumtoxinA) - PubMed Central

A Snapshot History of Botox - Dimensionz Injectables

How to prevent gray market activities: A comprehensive checklist for pharmaceutical companies - Systech

FDA Approves First Over-the-Counter Naloxone Nasal SprayUS. Food and Drug Administration

Oral Insulin: The Rationale for This Approach and Current Developments - PubMed Central

ABOUT BALANCING THE FUTURE

Join Micah Schweizer and new host Chai Nussbaumer on Balancing the Future as they dive into the innovations shaping our world. From the potential of hydrogen in powering a greener planet, to the rise of GLP-1s in weight loss, and the frontier of microbiome-based treatments, they explore the science that's transforming our lives.

Each episode features in-depth conversations with scientists, communicators, and thought leaders pushing the boundaries of what’s possible. They also explore the impact these breakthroughs will have on a world in desperate need of sustainable solutions today.


ABOUT METTLER TOLEDO LAB SOLUTIONS:

In the fast-paced world of laboratory science, precision and efficiency are everything. That’s why METTLER TOLEDO is committed to delivering cutting-edge laboratory solutions that streamline workflows and enhance productivity. Our comprehensive portfolio includes high-performance instruments, intuitive software, automation technologies, consumables, accessories, and expert services—each engineered to meet the unique needs of industries such as pharmaceuticals, food and beverage, chemicals, biotechnology, and both QA/QC and R&D laboratories.

From precision and analytical balances to advanced titrators, pH meters, density meters, refractometers, melting point instruments, and more, METTLER TOLEDO products are designed for accuracy, reliability, and ease of use. Our solutions empower laboratories to generate trusted results, maintain compliance, and ensure maximum uptime with our robust lifecycle services and automation capabilities.

  continue reading

14 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play